288 related articles for article (PubMed ID: 23094824)
21. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
[TBL] [Abstract][Full Text] [Related]
24. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
Beaugerie L; Brousse N; Bouvier AM; Colombel JF; Lémann M; Cosnes J; Hébuterne X; Cortot A; Bouhnik Y; Gendre JP; Simon T; Maynadié M; Hermine O; Faivre J; Carrat F;
Lancet; 2009 Nov; 374(9701):1617-25. PubMed ID: 19837455
[TBL] [Abstract][Full Text] [Related]
25. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
[TBL] [Abstract][Full Text] [Related]
26. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
Casanova MJ; Chaparro M; Domènech E; Barreiro-de Acosta M; Bermejo F; Iglesias E; Gomollón F; Rodrigo L; Calvet X; Esteve M; García-Planella E; García-López S; Taxonera C; Calvo M; López M; Ginard D; Gómez-García M; Garrido E; Pérez-Calle JL; Beltrán B; Piqueras M; Saro C; Botella B; Dueñas C; Ponferrada A; Mañosa M; García-Sánchez V; Maté J; Gisbert JP
Am J Gastroenterol; 2013 Mar; 108(3):433-40. PubMed ID: 23318480
[TBL] [Abstract][Full Text] [Related]
27. State-of-the-art: Immunosuppression and biologic therapy.
Sandborn WJ
Dig Dis; 2010; 28(3):536-42. PubMed ID: 20926883
[TBL] [Abstract][Full Text] [Related]
28. Is there a risk for lymphoma or extracolonic cancer in patients with inflammatory bowel disease?
Toader E; Ciortescu I
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):368-74. PubMed ID: 24340518
[TBL] [Abstract][Full Text] [Related]
29. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Dayharsh GA; Loftus EV; Sandborn WJ; Tremaine WJ; Zinsmeister AR; Witzig TE; Macon WR; Burgart LJ
Gastroenterology; 2002 Jan; 122(1):72-7. PubMed ID: 11781282
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
32. [Inflammatory bowel diseases and lymphoma].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
[TBL] [Abstract][Full Text] [Related]
33. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
34. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
36. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
[TBL] [Abstract][Full Text] [Related]
37. [Hematologic malignant complications after transplantation].
Caillard S; Imhoff O; Moulin B
Nephrol Ther; 2011 Nov; 7(6):500-12. PubMed ID: 21531185
[TBL] [Abstract][Full Text] [Related]
38. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
